Genetic testing for pancreatic cancer risk
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study offers genetic testing to people at higher risk for pancreatic cancer, especially those with a family history or certain genetic changes. It aims to help you understand your risk and possibly catch cancer early.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 50 or older, or within 10 years of the age when a family member was diagnosed with pancreatic cancer.
- You have Medicaid, or you are Black or Latino/a.
- You live in Massachusetts and can travel to Boston for follow-up tests if needed.
- You have a parent, sibling, or child with pancreatic cancer, or a blood relative with a known genetic change linked to pancreatic cancer.
- You have not had genetic testing for pancreatic cancer risk before.
- You have internet access and can complete surveys in English.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is building a registry of people with a strong family history of pancreatic cancer. By joining, you help researchers learn more about who is at risk and how to detect it early.
This study is a registry (a way to track health over time) for people with a strong family history or certain inherited genetic risks for pancreatic cancer. It may help doctors learn how best to monitor and protect high-risk people, and to see who benefits most from follow-up.
This trial uses MRI and endoscopic ultrasound to look for early signs of pancreatic cancer in people who have a high risk due to their genes or family history. Finding it early may lead to better treatment options.
This study offers pancreatic cancer screening for people with strong family history or certain inherited gene changes. It may help find pancreatic cancer earlier, when treatment may be more effective.
This trial tests ways to screen people who have a family-passed (inherited) gene mutation linked to higher pancreatic cancer risk. The goal is to find pancreatic cancer earlier and improve how screening is done for people at increased risk.
This study offers personalized education and genetic counseling to help people with a close family history of pancreatic cancer understand their risk and decide about genetic testing. It is only for current Mayo Clinic Florida patients in certain clinics.
Hear when a new Pancreatic Ductal Adenocarcinoma (PDAC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.